Acciones NuGenerex Immuno-Oncology, Inc.
Acciones
NUGX
US67053X1028
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 01/01/17 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | - |
Eric von Hofe
PSD | President | 66 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marvin Hausman
BRD | Director/Board Member | 82 | - |
Brian T. McGee
BRD | Director/Board Member | 63 | - |
Carol A. Nacy
BRD | Director/Board Member | 76 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,49 % | 104 mil M | |
+1,36 % | 97,42 mil M | |
+0,79 % | 22,2 mil M | |
-17,85 % | 21,23 mil M | |
-11,11 % | 18,33 mil M | |
-42,83 % | 16,35 mil M | |
-15,97 % | 15,06 mil M | |
+3,83 % | 13,98 mil M | |
+34,47 % | 11,66 mil M |